Objective: A solid understanding of levels and trends of spending on cancer is important to evaluate whether our healthcare resources were wisely spent and to prioritize future resources for cancer treatment and preve...Objective: A solid understanding of levels and trends of spending on cancer is important to evaluate whether our healthcare resources were wisely spent and to prioritize future resources for cancer treatment and prevention. However, studies on economic burden of cancers in China are scant and the results are inconsistent. Methods: The Chinese hospital information database and nearly 350 million inpatient medical record data were used. As the ratios of cancer inpatient payments to total inpatient payments were mainly influenced by the grades and sites of hospitals, the estimates of payments of cancer inpatients in this study were stratified by hospital grades and provinces. Only the payments of cancer inpatients happened in grade 2, grade 3 and specialized cancer hospitals were included in the analyses. The total medical payments of cancers in China were estimated based on the ratios of outpatient payments to inpatient payments in specialized cancer hospitals. Results: From 2011 to 2015, the payments of cancer inpatients in China have increased by 84.1% and the total inpatient payments reached 177.1 billion RMB in 2015, accounting for 4.3% of the total health expenditure in China. Based on the ratio of outpatient payments to inpatient payments, the total payments on cancer treatments in China were estimated to be 221.4 billion RMB in 2015. Among different cancer types, the highest payments were the treatment of trachea, bronchus and lung cancer. The major cancer inpatient payments (67.1% in 2015) spent in grade 3 general hospitals and this ratio increased continually from 2011 to 2015. The expenditure of cancer treatments also varies by region with the major expenditure in the eastern region of China. Conclusions: This study estimated the total payments of cancer treatments in China and analyzed how the money was spent on cancer treatments in the recent 5 years, which would provide information for decision makings on the allocation of resources to service provisioning, prevention strategies, research funding, and 展开更多
目的了解中国流感经济负担研究现状并总结主要结果。方法以流感、流行性感冒、成本、经济、负担、费用、效益、效用和效果,以及influenza、flu、cost、economic、burden、effectiveness、benefit、utility、China和Chinese为关键词,系...目的了解中国流感经济负担研究现状并总结主要结果。方法以流感、流行性感冒、成本、经济、负担、费用、效益、效用和效果,以及influenza、flu、cost、economic、burden、effectiveness、benefit、utility、China和Chinese为关键词,系统检索中国知网、万方数据知识服务平台、Pubmed、Web of science、EconLit和Cochrane Library等数据库中2000—2018年中国流感经济负担的经济学研究相关文献,语种限定为中文和英文,共纳入23篇有效文献,对纳入文献的基本信息、研究指标及方法进行分析,经济相关指标的单位均为元人民币。结果23篇文献主要集中在经济发达、人口较多的地区,6篇文献报道了全年龄组流感确诊病例的总经济负担,其中,4篇报告了门诊病例人均总经济负担,其范围为768.0~999.9元,1篇报告了住院病例的该项指标(9832.0元);1篇文献报告了流感样病例人均门诊总经济负担,为205.1元。1篇文献报告了5岁以下儿童住院病例人均直接医疗费用为6072.0元,而有2篇文献报告了60岁及以上老年人的此项指标,其范围为14250.0~19349.1元。4篇文献报告了城市和农村的流感经济负担,其中1篇显示,城市流感住院患者相关费用占年均收入的比例为31%,而农村为113%。结论中国流感确诊病例平均经济负担高于流感样病例,其中门诊间接费用及住院直接医疗费用差异较大。流感住院病例中60岁及以上年龄组的直接医疗负担较重。农村地区流感导致个人经济负担高于城市地区。展开更多
基金supported by National Natural Science Foundation of China (No.71403189)
文摘Objective: A solid understanding of levels and trends of spending on cancer is important to evaluate whether our healthcare resources were wisely spent and to prioritize future resources for cancer treatment and prevention. However, studies on economic burden of cancers in China are scant and the results are inconsistent. Methods: The Chinese hospital information database and nearly 350 million inpatient medical record data were used. As the ratios of cancer inpatient payments to total inpatient payments were mainly influenced by the grades and sites of hospitals, the estimates of payments of cancer inpatients in this study were stratified by hospital grades and provinces. Only the payments of cancer inpatients happened in grade 2, grade 3 and specialized cancer hospitals were included in the analyses. The total medical payments of cancers in China were estimated based on the ratios of outpatient payments to inpatient payments in specialized cancer hospitals. Results: From 2011 to 2015, the payments of cancer inpatients in China have increased by 84.1% and the total inpatient payments reached 177.1 billion RMB in 2015, accounting for 4.3% of the total health expenditure in China. Based on the ratio of outpatient payments to inpatient payments, the total payments on cancer treatments in China were estimated to be 221.4 billion RMB in 2015. Among different cancer types, the highest payments were the treatment of trachea, bronchus and lung cancer. The major cancer inpatient payments (67.1% in 2015) spent in grade 3 general hospitals and this ratio increased continually from 2011 to 2015. The expenditure of cancer treatments also varies by region with the major expenditure in the eastern region of China. Conclusions: This study estimated the total payments of cancer treatments in China and analyzed how the money was spent on cancer treatments in the recent 5 years, which would provide information for decision makings on the allocation of resources to service provisioning, prevention strategies, research funding, and
文摘目的了解中国流感经济负担研究现状并总结主要结果。方法以流感、流行性感冒、成本、经济、负担、费用、效益、效用和效果,以及influenza、flu、cost、economic、burden、effectiveness、benefit、utility、China和Chinese为关键词,系统检索中国知网、万方数据知识服务平台、Pubmed、Web of science、EconLit和Cochrane Library等数据库中2000—2018年中国流感经济负担的经济学研究相关文献,语种限定为中文和英文,共纳入23篇有效文献,对纳入文献的基本信息、研究指标及方法进行分析,经济相关指标的单位均为元人民币。结果23篇文献主要集中在经济发达、人口较多的地区,6篇文献报道了全年龄组流感确诊病例的总经济负担,其中,4篇报告了门诊病例人均总经济负担,其范围为768.0~999.9元,1篇报告了住院病例的该项指标(9832.0元);1篇文献报告了流感样病例人均门诊总经济负担,为205.1元。1篇文献报告了5岁以下儿童住院病例人均直接医疗费用为6072.0元,而有2篇文献报告了60岁及以上老年人的此项指标,其范围为14250.0~19349.1元。4篇文献报告了城市和农村的流感经济负担,其中1篇显示,城市流感住院患者相关费用占年均收入的比例为31%,而农村为113%。结论中国流感确诊病例平均经济负担高于流感样病例,其中门诊间接费用及住院直接医疗费用差异较大。流感住院病例中60岁及以上年龄组的直接医疗负担较重。农村地区流感导致个人经济负担高于城市地区。
